Evidence map›Paper›PMID 42256587›Full record

ArticleDiabetology international2026

Phase angle, extracellular to intracellular water ratio, and advanced glycation end products according to four sarcopenia categories and in relation to muscle strength/mass in elderly out-patients with diabetes.

Toshihiro Amagawa, Hiroki Yokoyama, Yumiko Teramoto, Youko Fujimaki, Atsushi Ohno, Hiroshi Takamura

Abstract read
In one paragraph

Article in Diabetology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Toshihiro AmagawaDepartment of Diabetology and Endocrinology and Metabolism, Tokyo Medical University Hachioji Medical Center, Tatemachi, Hachioji, 1163 Japan.
Hiroki YokoyamaInternal Medicine, Jiyugaoka Medical Clinic, West 6, South 6-4-3, Obihiro, 080-0016 Japan.ORCID 0000-0003-1602-4050
Yumiko TeramotoTakamura Clinic, Fussa, 1044 Japan.
Youko FujimakiTakamura Clinic, Fussa, 1044 Japan.
Atsushi OhnoTakamura Clinic, Fussa, 1044 Japan.
Hiroshi TakamuraTakamura Clinic, Fussa, 1044 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Sarcopenia is classified into normal, presarcopenia, dynapenia, and sarcopenia according to muscle strength/mass. As assessment methods for muscle strength and mass, phase angle (PhA), extracellular water/intracellular water ratio (ECW/ICW), and advanced glycation end products (AGEs) have been developed. We investigated the proportions in elderly outpatients with diabetes and elucidate clinical characteristics, including PhA, ECW/ICW, and AGEs among the four groups. Methods: A cross-sectional study was performed in 695 patients with diabetes aged 65 years or older, who were classified according to the classification proposed by the Asian Working Group for Sarcopenia. Clinical characteristics of the four groups were compared by ANOVA. Associations of grip strength and skeletal muscle index (SMI) with PhA, ECW/ICW, and AGEs and interrelations among grip strength, SMI, PhA, ECW/ICW, and AGEs were analyzed by multiple linear regression analyses. Results: Proportions of those (male/female, %) classified as normal, presarcopenia, dynapenia, and sarcopenia were 42.3/42.9, 30.3/26.6, 19.9/21.0, and 7.4/9.4, respectively. In order from normal, presarcopenia, dynapenia, and sarcopenia, age, ECW/ICW, and AGEs increased, while grip strength, gait speed, and PhA decreased ( Conclusions: PhA, ECW/ICW, and AGEs were significantly different according to the four sarcopenia groups, and ECW/ICW was independently associated with both grip strength and SMI.

Indexed as

Advanced glycation end productsDiabetesExtracellular water/intracellular water ratioPhase angleSarcopenia

Identifiers

PMID42256587
PMCPMC13241559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.